Public Profile

Zoetis

Zoetis Inc., headquartered in the United States, is a leading global animal health company dedicated to supporting the health and well-being of livestock and companion animals. Founded in 1952, Zoetis has established itself as a pioneer in the veterinary pharmaceutical industry, with a diverse portfolio that includes vaccines, diagnostics, and therapeutics. With a strong presence in North America, Europe, and Asia, Zoetis is renowned for its innovative products that enhance animal health and productivity. The company’s commitment to research and development has led to significant milestones, including the introduction of groundbreaking treatments that address various health challenges in animals. Recognised for its market leadership, Zoetis continues to set industry standards, making it a trusted partner for veterinarians and animal producers worldwide.

DitchCarbon Score

How does Zoetis's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

55

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Zoetis's score of 55 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.

90%

Let us know if this data was useful to you

Zoetis's reported carbon emissions

In 2023, Zoetis reported total carbon emissions of approximately 232,804,000 kg CO2e from Scope 1 and 2 sources, with Scope 1 emissions at about 111,637,000 kg CO2e and Scope 2 emissions at approximately 121,167,000 kg CO2e (market-based). Additionally, Scope 3 emissions, which include business travel and employee commuting, amounted to about 36,349,000 kg CO2e. Zoetis has set ambitious climate commitments, aiming to achieve carbon neutrality in its operations by 2030, focusing on reducing Scope 1 and 2 emissions. This goal includes an 18.9% reduction in these emissions. Furthermore, the company is targeting a 5% reduction in energy intensity for both manufacturing and research and development by 2025, using 2019 as a baseline. The company's emissions data reflects a commitment to sustainability and responsible environmental practices, aligning with industry standards for climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2017201820192020202120222023
Scope 1
73,391,000
00,000,000
00,000,000
00,000,000
000,000,000
000,000,000
000,000,000
Scope 2
193,434,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
00,000,000
-
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zoetis's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Zoetis is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zoetis is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Dechra

GB
Pharmaceutical Preparation Manufacturing
Updated 23 days ago

Elanco Tiergesundheit AG

CH
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Zimmer Biomet

US
Medical, precision and optical instruments, watches and clocks (33)
Updated 4 days ago

Boehringer Ingelheim Corporation

US
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Mallinckrodt plc

IE
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Viatris

US
Pharmaceutical Preparation Manufacturing
Updated 11 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers